Richter BioLogics

Das neue Jahrbuch der BIO Deutschland e. V. ist erschienen. Auch dieses Jahr sind wir mit einem Beitrag dabei. Lesen Sie mehr über unsere Expertise im Bereich der GMP Herstellung und warum vertrauensvolle Partnerschaften mit unseren Kunden uns so wichtig sind. https://lnkd.in/em8MqwRV

Curious about the potential of yeast and bacteria in biopharmaceutical manufacturing? Dr. Kai Pohlmeyer, CEO of Richter BioLogics GmbH & Co. KG, shares insights in an exclusive interview with Handelsblatt. Discover how Richter BioLogics is shaping the future of drug substance production and meeting global demand in the fast-growing biopharma market. Read the full interview for cutting-edge insights that could transform your approach to drug development. 🔗 Link to Interview https://lnkd.in/eJ_6_KmT #Biologics #CDMO #RichterBioLogics

Last day of Bio Europe in Stockholm! Our team is ready to welcome you and talk about your specific needs for Biologics manufacturing. Why meet us? ·      Expertise in bacteria and yeast-derived products (antibodies (VHH/ Nanobodies), pDNA, proteins, and more) ·      State-of-the-art GMP-compliant facilities ·      Customized solutions to meet your specific needs We'd love to schedule a meeting with your team at our booth # 36 to discuss how we can support your project’s success. 🤝 #BioEurope #RichterBiologics #Biologics #CDMO

Our team has landed in Stockholm for Bio Europe 2024. We are excited to showcase our comprehensive, one-stop-shop offerings tailored to meet your specific needs for your protein- and pDNA-based projects. If you're attending, we would love to connect and discuss how we can support your business goals. Let's explore opportunities together! Reach out to schedule a meeting or stop by our booth 36 - you can´t miss it. See you at the event! #BioEurope2024 #CDMO #RichterBioLogics

In September we had the fantastic opportunity to attend the LabVantage CTEC EMEA in Malmö. Two of our experts presented our vision for a Laboratory Information Management System (LIMS) in our quality control laboratories. This vision will significantly improve the efficiency and accuracy of our laboratory processes. A key element of our strategy is an iterative implementation approach. This approach is designed to deliver value quickly and to continually extend and improve functionality. Feedback from vendors and other users has confirmed that we are on the right track. The LIMS will enable us to further improve our service to our customers. We look forward to taking the next steps in this exciting development and taking our laboratories to a new level of efficiency.

In today’s competitive market, sustainability isn’t just a trend. To remain at the forefront of the industry, it’s vital to integrate environmentally responsible practices into your operations. Keen on understanding the implications of the new Corporate Sustainability Reporting Directive (CSRD) in Europe for SMEs? To find out more, dive into the article written by one of our experts and shared here! At Richter BioLogics, we've taken steps towards these topics, contributing to a more sustainable future while securing our long-term success. The way forward demands dedication and innovation, but we believe the advantages will far outweigh the efforts. Click on the link to read more about how the CSRD will reshape the sustainability efforts of medium-sized companies published in Pharma Nature Positive, page 24: https://lnkd.in/dkZD_6XU #CSRD #Sustainability #RichterBioLogics

We're excited to announce our participation in Bio Europe 2024 from November 4 - 6. 🌍 We are eager to collaborate with pharmaceutical leaders, consultants, and business partners at this pivotal event. With over 35 years in the industry, we've established ourselves as a trusted partner, delivering high-level CDMO solutions that safeguard patient lives and enhance health outcomes. Why meet us? ·      Expertise in bacteria and yeast-derived products (antibodies (VHH/ Nanobodies), pDNA, proteins, and more) ·      State-of-the-art GMP-compliant facilities ·      Customized solutions to meet your specific needs If you're attending, we'd love to connect! Schedule a meeting with our team at our booth # 36 to discuss how we can support your project’s success. Let's innovate together! 🤝 #BioEurope #Pharmaceuticals #CDMO

A month ago we inaugurated our new production facility, which triples our production capacity by adding 2 production lines of 1500 and 300 litres. What this means for Richter BioLogics and what the future holds, you can read in the interview with our Managing Director Dr Kai Pohlmeyer with the Life Science Nord magazine, linked here. https://lnkd.in/ec4mJ5MD

Arrivederci al CPhI di Milano! The whole team enjoyed the open, communicative and busy atmosphere at CPhI, all days were packed with good conversations and great networking. We would like to thank everyone who made this event such a great experience and success for us. 🚀 Maybe we'll see you in Stockholm soon! #CDMO #CPhI

Today is finally the day, the first day of CPhI in Milan. Come and visit us in hall 3 at stand 3F129. You can't miss Richter BioLogics (formerly Richter-Helm). We look forward to seeing you and having great conversations! #CPhI #CDMO